Atlas Trials

Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy

Clinical trial NCT02299050 · COMPLETED

Trial details

NCT number
NCT02299050
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2014-06-01
Primary completion
2018-04-30
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.